Medicine is and always has been full of unproven concepts. However, when they are frequently used in clinical practice, they seem established and are therefore seldom questioned. In his book ‘Follies and fallacies in medicine’ (Glasgow, The Tarragon Press, 1989) Peter Skrabanek clearly proposed a way to improve the quality of medicine by being chronically sceptical towards all ‘established’ concepts. By cyting Bertold Brecht he proposed ‘scepticemia’ as a major tool to speed up the progress in medicine: ‘The chief cause of poverty in science is imaginary wealth. The chief aim of science is not to open a door to infinite wisdom but to set a limit to infinite error.’ In this article we will try to analyze the evidence of the three so-called cornerstones of diabetes therapy – diet, exercise and insulin – with regard to their efficacy in reaching the goals of treatment in type 1 (insulin-dependent) diabetes.

1.
Joslin EP, Root HF, White P, Marble A: The Treatment for Diabetes mellitus, ed 5, Philadelphia, Lea & Febiger, 1935.
2.
Mogensen CE, Standl E (eds): Concepts for the Ideal Diabetes Clinic. Diabetes Forum series, vol 4. Berlin, Walter de Gruyter.
3.
The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.
4.
Lawrence RD: The effect of exercise on insulin action in diabetes. Br Med J 1926;i:648–652.
5.
Katsch G: Arbeitstherapie der Zuckerkranken. Erg Physikal Diät Ther 1939;1:1–36.
6.
Giacca A, Vranic M, Davidson JK, Lickley HLA: Exercise and stress in diabetes mellitus; in Davidson JK (ed): Clinical Diabetes. A Problem-Oriented Approach. New York, Thieme, 1991, pp 218–265.
7.
Krall LP: Joslin Diabetes Manual, ed 12. Philadelphia, Lea & Febiger, 1985.
8.
Gudat U, Berger M: Diabetes and exercise; in Mogensen CE, Standl E (eds): Concepts for the Ideal Diabetes Clinic. Diabetes Forum Series, vol 4. Berlin, Walter de Gruyter, 1993, pp 171–185.
9.
Wallberg-Henriksson H, Gunnarson R, Henriksson J, DeFronzo RA, Felig P, Östman J, Wahren J: Increased peripheral insulin sensitivity in and muscle mitochondrial enzymes but unchanged blood glucose control in type 1 diabetics after physical training. Diabetes 1982;31:1044–1050.
10.
Zinman B, Zuniga-Guajardo S, Kelly D: Comparison of the acute and long-term effects of exercise on glucose control in type I diabetes. Diabetes Care 1984;7:515–519.
11.
Stratton RL, Wilson DP, Endres RK, Doldstein DE: Improved glycemic control after supervised 8-wk exercise program in insulin-dependent diabetic adolescents. Diabetes Care 1987;10:589–593.
12.
Campaigne BN, Wallberg-Henriksson H, Gunnarsson R: Glucose and insulin response in relation to insulin dose and caloric intake 12 h after acute physical exercise in men with IDDM. Diabetes Care 1987;10:716–721.
13.
MacDonald MJ: Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care 1987;10:584–588.
14.
Kemmer FW, Berger M: Exercise; in Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds): International Textbook of Diabetes mellitus. Chichester, Wiley, 1992, pp 725–743.
15.
Chantelau EA: Relation of dietary barriers in patients with insulin-dependent diabetes mellitus to different modes of treatment. J Am Diet Assoc 1992;92:1129–1131.
16.
Schweizerische Diabetes Gesellschaft: Der gesunde Zuckerkranke, ed 3. Schweizerische Diabetes Gesellschaft, 1981.
17.
Oyen D, Chantelau EA, Berger M: Zur Geschichte der Diabetes Diät. Berlin, Springer, 1985.
18.
Mehnert H: Ernährungstherapie; in Mehnert H, Schöffling K, Standl E, Usadel KH (eds): Diabetologie in Klinik und Praxis, ed 3. Stuttgart, Thieme, 1994, pp 162–210.
19.
Allen FN: Experimental studies with diabetes. I. Production and control of diabetes in the dog: Effects of carbohydrate diets. J Exp Med 1920;31:381–402.
20.
Slama G, Haardt MJ, Jean-Joseph P, Costagliola D, Goicolea I, Bornet F, Elgrably F, Tchobroutsky G: Sucrose taken during mixed meal has no additional hyperglycemic action over isocaloric amounts of starch in well-controlled diabetics. Lancet 1984;ii:122–125.
21.
Nathan DM, Godine JE, Gauthier-Kelley C, Kawahara D, Grinvalsky M: Ice cream in the diet of insulin-dependent diabetic patients. JAMA 1984;251:2825–2827.
22.
Chantelau EA, Sonnenberg GE, Stanitzek-Schmidt I, Best F, Altenähr H, Berger M: Diet liberalization and metabolic control in type-1 diabetic outpatients treated with continuous subcutaneous insulin infusion. Diabetes Care 1982;5:612–616.
23.
Chantelau EA, Gösseringer G, Sonnenberg GE, Berger M: Moderate intake of sucrose does not impair metabolic control in pump-treated diabetic out-patients. Diabetologia 1985;28:204–207.
24.
Chantelau EA, Bockholt M, Lie KT, Broermann C, Sonnenberg GE, Berger M: Diet and pump-treated diabetes: A long-term follow-up. Diabète Metab 1983;9:277–282.
25.
Chantelau EA, Frenzen A, Gösseringer G, Hansen I, Berger M: Intensive insulin therapy justifies simplification of the diabetes diet: A prospective study in insulin-dependent diabetic patients. Am J Clin Nutr 1987;45:958–962.
26.
Chantelau EA, Spraul M, Mühlhauser I, Gause R, Berger M: Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type-1 (insulin-dependent) diabetes mellitus: A one centre experience. Diabetologia 1989;32:421–426.
27.
Venhaus A, Chantelau E: Self-selected unrefined and refined carbohydrate diets do not affect metabolic control in pump-treated diabetic patients. Diabetologia 1988;31:153–157.
28.
American Diabetes Association: Position statement. Nutrition recommendations and principles for individuals with diabetes mellitus:1986. Diabetes Care 1987;10:126–132.
29.
Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes – 1988: Nutritional recommendations for individuals with diabetes mellitus. Diab Nutr Metab 1988;1:145–149.
30.
Mühlhauser I, Bott U, Overmann H, Wagener W, Bender R, Jörgens V, Berger M: Liberalized diet in patients with type 1 diabetes. J Intern Med 1995;235:591–597.
31.
Chantelau EA: Diät (?) bei Diabetes mellitus; in Berger M (ed): Diabetes mellitus. München, Urban & Schwarzenberg, 1995, pp 126–157.
32.
Kinmouth AL, Baum JD: Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children. Br Med J 1980;280:604–606.
33.
Kraegen EW, Chisholm DJ, McNamara ME: Timing of insulin delivery with meals. Horm Metab Res 1981;13:365–367.
34.
Dimitriadis GD, Gerich JE: Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 1983;6:374–377.
35.
Witt MF, White NH, Santiago JV: Roles of site and timing of the morning insulin injection in type 1 diabetes. J Paediatr 1983;103:528–533.
36.
Lean MEJ, Ng LL, Tennison BR: Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br J Med 1985;290:105–108.
37.
Heinemann L, Starke AAR, Hohmann A, Berger M: Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal. Horm Metab Res 1992;26(suppl):137–139.
38.
Overmann H, Heinemann L: Injection-meal interval: What do diabetologists recommend to their patients (abstract). Diabetologia 1997;40(suppl 1):A620.
39.
Heinemann L: Do insulin-treated diabetic patients use an injection-meal-interval in daily life? Diabetes Med 1995;12:449–450.
40.
Berger M, Jörgens V: Praxis der Insulintherapie, ed 5. (ed 1, 1983). Berlin, Springer, 1995.
41.
Berger M, Heinemann L: Are presently available insulin analogues clinically beneficial? Diabetologia 1997;40(suppl 2):S91–S97.
42.
Reichard P, Pihl M: Mortality and side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention study. Diabetes 1994;43:313–317.
43.
Pieber TR, Brunner GA, Schnedel WJ, Schattenberg S, Kaufmann P, Krejs GJ: Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 1995;18:625–630.
44.
Pampanelli S, Fanelli C, Lalli C, Ciofetta M, Sindaco PD, Lepore M, Modarelli F, Rambotti AM, Epifano L, Di-Vincenzo A, Bartocci L, Annibale B, Brunetti P, Bolli GB: Long-term intensive insulin therapy in IDDM: Effects on HbA1c, risk for severe and mild hypoglycemia, status of counterregulation and awareness of hypoglycemia. Diabetologia 1996;39:677–686.
45.
Mecklenburg RS, Benson EA, Benson JW: Acute complications associated with insulin infusion pump therapy. JAMA 1994;252:3265–3269.
46.
Jörgens V, Grüsser M, Bott U, Mühlhauser I, Berger M: Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia 1993;36:99–105.
47.
Bending JJ, Pickup JC, Keen H: Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Am J Med 1985;79:685–691.
48.
Mühlhauser I, Bruckner I, Berger M, Cheta D, Jörgens V, Ionescu-Tirgoviste C, Scholz V, Mincu I: Evaluation of an intensified treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study. Diabetologia 1987;30:681–690.
49.
Starostina EG, Antsiferov M, Galstyan GR, Trautner C, Jörgens V, Bott U, Mühlhauser I, Berger M, Dedov IL: Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for type 1 (insulin dependent) diabetes mellitus in Moscow-blood glucose versus urine glucose self-monitoring. Diabetologia 1994;37:170–176.
50.
Berger M, Mühlhauser I: Implementation of intensified insulin therapy: A European perspective. Diabetes Med 1995;12:201–208.
51.
Bott S, Bott U, Berger M, Mühlhauser M: Intensified insulin therapy and the risk of severe hypoglycemia. Diabetologia 1997;40:926–932.
52.
The Diabetes Control and Complications Trial Research Group: Implementation of treatment protocols in the DCCT. Diabetes Care 1995;18:361–376.
53.
Mühlhauser I, Berger M: Diabetes education and insulin therapy: When will they ever learn. J Intern Med 1993;233:321–326.
54.
Stolte K, Wolff J: Die Behandlung der kindlichen Zuckerkrankheit bei frei gewählter Kost. Ergeb Inn Med Kinderheilk 1939;56:154–193.
55.
Berger M: To bridge science and patient care in diabetes. Diabetologia 1996;39:749–757.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.